Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Stender

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 2011
Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general populationStefan Stender, Ruth Frikke-Schmidt, Aristomenis Anestis, et al.
European Heart Journal|December 12, 2017
Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individualsBo Kobberø Lauridsen, Stefan Stender, Thomas Skårup Kristensen, et al.
Nature Medicine|April 13, 2026
Plasma proteomic signature of the human menstrual cycleIben Riishede, Line Rode, Pia Rengtved Lundegaard, et al.
Nature Genetics|February 18, 2014
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver diseaseJulia Kozlitina, Eriks Smagris, Stefan Stender, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2023
Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization studyHelene Gellert-Kristensen, Anne Tybjaerg-Hansen, Børge G Nordestgaard, et al.
Hepatology (Baltimore, Md.)|December 22, 2017
Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglycerideStefan Stender, Eriks Smagris, Bo K Lauridsen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2019
The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and AdolescentsMagnus J Johansen, Julie Gade, Stefan Stender, et al.
Clinics and Research in Hepatology and Gastroenterology|June 3, 2024
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general populationElias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2020
Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver FibrosisMads Israelsen, Helene Bæk Juel, Sönke Detlefsen, et al.
Atherosclerosis|April 29, 2026
Lipoprotein(a), interleukin-6 and cardiovascular risk in a primary prevention settingJohan Skov Bundgaard, Søren Albertsen Rand, Stefan Stender, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 2011
Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general populationStefan Stender, Ruth Frikke-Schmidt, Aristomenis Anestis, et al.
European Heart Journal|December 12, 2017
Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individualsBo Kobberø Lauridsen, Stefan Stender, Thomas Skårup Kristensen, et al.
Nature Medicine|April 13, 2026
Plasma proteomic signature of the human menstrual cycleIben Riishede, Line Rode, Pia Rengtved Lundegaard, et al.
Nature Genetics|February 18, 2014
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver diseaseJulia Kozlitina, Eriks Smagris, Stefan Stender, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2023
Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization studyHelene Gellert-Kristensen, Anne Tybjaerg-Hansen, Børge G Nordestgaard, et al.
Hepatology (Baltimore, Md.)|December 22, 2017
Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglycerideStefan Stender, Eriks Smagris, Bo K Lauridsen, et al.
The Journal of Clinical Endocrinology and Metabolism|October 17, 2019
The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and AdolescentsMagnus J Johansen, Julie Gade, Stefan Stender, et al.
Clinics and Research in Hepatology and Gastroenterology|June 3, 2024
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general populationElias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2020
Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver FibrosisMads Israelsen, Helene Bæk Juel, Sönke Detlefsen, et al.
Atherosclerosis|April 29, 2026
Lipoprotein(a), interleukin-6 and cardiovascular risk in a primary prevention settingJohan Skov Bundgaard, Søren Albertsen Rand, Stefan Stender, et al.
Pageof 6